Last updated: 11/07/2018 07:03:59

Korean practice patterns for screening PCA(prostate cancer)RESPECT

GSK study ID
113951
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Korean’s practice patterns for screening PCA(prostate cancer) according to PSA(prostate-specific antigen) level
Trial description: This is to investigate Korean urologist’s practice patterns for screening prostate cancer according to PSA level.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Number of subjects with prostate biopsy

Timeframe: 1year

Secondary outcomes:

Number of subjects with prostate cancer

Timeframe: 1year

Interventions:
  • Other: continuous screening
  • Enrollment:
    1
    Primary completion date:
    Not applicable
    Observational study model:
    Other
    Time perspective:
    Retrospective
    Clinical publications:
    Mun Su Chung, Seung Hwan Lee , Dong Hoon Lee, Se Joong Kim, Choung Soo Kim, Kyu Sung Lee, Jae Il Jung, Sae Woong Kim, Yil Seob Lee, Byung Ha Chung. Practice Patterns for Screening and Managing Prostate Cancer according to PSA level (RESPECT Study). Yonsei Med J. 2012;53(6):1136-1141.
    Medical condition
    Neoplasms, Prostate, Benign Prostatic Hyperplasia
    Product
    Not applicable
    Collaborators
    Not applicable
    Study date(s)
    May 2010 to June 2011
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Male
    Age
    40+ years
    Accepts healthy volunteers
    No
    • Male with PSA more than 2.5ng/ml from 1 Jan 2008 to 31 Dec 2008
    • Age less than 40 at PSA screening
    • History of drug use which can affect level of PSA within 6months before PSA screening

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    Seoul, South Korea, 135-720
    Status
    Study Complete

    Study documents

    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2011-30-06

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website